Prof. Paul H.M. Savelkoul PhD
Mr. Savelkoul is professor of Medical Microbiology at the VU University Medical Center. He is head of the section Molecular Diagnostics of the aforementioned department. Additionally, professor Savelkoul is actively involved in several professional committees, for example as chairman of the European Study Group on Molecular Diagnostics and the Dutch Section Microbial Characterization. His research expertise is on molecular diagnostics, detection and typing of pathogenic micro-organisms and molecular epidemiology. Professor Savelkoul is one of the founders of Microbiome.
Prof. Servaas Morré PhD
Prof. Morré is head Laboratory of Immunogenetics at the department of Pathology of the VU University Medical Center. His research is focused on the immunogenetics of chronic inflammatory diseases and infectious diseases, among which Chlamydia trachomatis, periodontitis and bacterial meningitis. He has 15 years of experience in Chlamydia trachomatis research. In addition, he is scientific director of the European FP6 EpiGenChlamydia Consortium, chairman of the European Society for Chlamydia Research for the 7th ESCR Meeting (2012) in Amsterdam and since 2009 coordinator of some core tasks of the National Institute of Public Health and the Environment (RIVM) concerning Chlamydia trachomatis. He is co-founder and scientific director of Microbiome and uses the knowledge he obtained during the Masterclass BioBusiness (2009-2010) for the development of new products.
R & D Manager
Mr. Catsburg works at the Department of Medical Microbiology and Infection Prevention of the VU University Medical Center. His internship focused on Real-Time PCR (TaqMan) qualification and quantification of Bifidobacterium, Propionibacterium and Streptococcus in mucosal biopsies from patients with inflammatory bowel disease. After this, he continued his work in the field of molecular microbiology. He developed Real-Time PCR tests for frequent diagnostic use. The targets were M. tuberculosis, T. whipplei, Mycoplasma and Chlamydia trachomatis. In addition, he developed a SNP assay that can be used for genotyping MBL (Mannose Binding Lectin). Besides his activities for Microbiome, which mostly concern research and development, he started writing his thesis about the Chlamydia trachomatis infection.